Evidence map›Paper›PMID 40846971›Full record

ReviewBMC biology2025

Iron metabolism and ferroptosis in human health and disease.

Meijuan Zhong, Yuandi Wang, Junxia Min, Fudi Wang

Abstract readReview
In one paragraph

Review in BMC biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

44 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Iron-Based Nanoparticles as Delivery Tools.Pharmaceuticals (Basel, Switzerland) · 2026
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Meijuan Zhong *School of Public Health, Hengyang Medical School, University of South China, Hengyang, 421001, China.
Yuandi Wang *School of Public Health, Hengyang Medical School, University of South China, Hengyang, 421001, China.
Junxia MinInstitute of Translational Medicine, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310058, China. junxiamin@zju.edu.cn.
Fudi WangSchool of Public Health, Hengyang Medical School, University of South China, Hengyang, 421001, China. fwang@zju.edu.cn.

Funding

Fudi Wang 32330047Junxia Min 82471593
6 · The paper itself

Abstract

Iron is indispensable to most lifeforms, underpinning a myriad of physiological processes. Dysregulation of iron homeostasis underlies a broad spectrum of biological phenomena and pathological conditions. Notably, excessive iron overload acts as a key driver of ferroptosis, a unique form of regulated cell death. Consequently, through the lens of ferrology, targeted modulation of iron balance and ferroptosis has emerged as a compelling avenue for the prevention and treatment of major diseases. Herein, we review the molecular mechanisms governing iron homeostasis, the roles of iron metabolism disorders and ferroptosis in disease pathogenesis, and the latest breakthroughs in iron-regulated therapeutic agents.

Indexed as

FerroptosisIronIron Metabolism DisordersAnimalsHomeostasisHumansIron OverloadIronFerrologyFerroptosisIron homeostasisIron supplementation

Identifiers

PMID40846971
PMCPMC12374342

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.